Impaired innate interferon induction in severe therapy resistant atopic asthmatic children

Mucosal Immunology

Volumn 6, Issue 4, 2013, Pages 797-806

  Edwards, M R ^a,b,c   Regamey, N ^d   Vareille, M ^d   Kieninger, E ^d   Gupta, A ^b,e   Shoemark, A ^b,e   Saglani, S ^b,e   Sykes, A ^b,e   MacIntyre, J ^a,b,c   Davies, J ^a,b,c   Bossley, C ^b,e   Bush, A ^b,e   Johnston, S L ^a,b,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; TOLL LIKE RECEPTOR 3;

ALLERGIC ASTHMA; ARTICLE; BRONCHIAL EPITHELIAL CELL; CHILD; CONTROLLED STUDY; DISEASE RESISTANCE; DISEASE SEVERITY; EPITHELIUM CELL; EX VIVO STUDY; GENE; HUMAN; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; RETINOIC ACID INDUCIBLE GENE; RHINOVIRUS; RHINOVIRUS INFECTION; VIRUS LOAD;

EID: 84879400685     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.118     Document Type: Article

References (47)

1. Johnston, S.L. et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310, 1225-1229 (1995).
2. Message, S.D. et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. USA 105, 13562-13567 (2008).
3. Corne, J.M. et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359, 831-834 (2002).
4. Johnston, N.W. et al. The September epidemic of asthma exacerbations in children: a search for etiology. J. Allergy Clin. Immunol. 115, 132-138 (2005).
5. Grunberg, K. et al. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am. J. Respir. Crit. Care Med. 164, 1816-1822 (2001).
6. Pauwels, R.A. et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N. Engl. J. Med. 337, 1405-1411 (1997).
7. Pauwels, R.A. et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361, 1071-1076 (2003).
8. FitzGerald, J.M. et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 59, 550-556 (2004).
9. Bel, E.H. et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 66, 910-917 (2011).
10. Bossley, C.J.et al. Pediatric severe asthma is characterized byeosinophilia and remodeling without T(H)2 cytokines. J. Allergy Clin. Immunol. 129, 974-82.e13 (2012).
11. Baraldo, S. et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J. Allergy Clin. Immunol. (2012) (in press).
12. Wark, P.A. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937-947 (2005).
13. Contoli, M. et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12, 1023-1026 (2006).
14. Uller, L. et al. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax 65, 626-632 (2010).
15. Iikura, K. et al. Peripheral blood mononuclear cells from patients with bronchial asthma show impaired innate immune responses to rhinovirus in vitro. Int Arch. Allergy Immunol. 155 (Suppl 1), 27-33 (2011).
16. Khaitov, M.R. [Acute respiratory viral infections and bronchial asthma. Cellular and molecular aspects of the problem]. Zh Mikrobiol. Epidemiol. Immunobiol., 84-93 (2002).
17. Wang, Q. etal. Roleof double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183, 6989-6997 (2009).
18. Slater, L. et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 6, e1001178 (2010).
19. Kotenko, S.V. et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4, 69-77 (2003).
20. Meager, A., Visvalingam, K., Dilger, P., Bryan, D. & Wadhwa, M. Biological activity of interleukins-28 and-29: comparison with type I interferons. Cytokine 31, 109-118 (2005).
21. Khaitov, M.R. etal. Respiratoryvirus inductionofalpha-, beta-andlambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64, 375-386 (2009).
22. Bochkov, Y.A. et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3, 69-80 (2010).
23. Proud, D. et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am. J. Respir. Crit. Care Med. 178, 962-968 (2008).
24. Schoggins, J.W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
25. Theofilopoulos, A.N., Baccala, R., Beutler, B. & Kono, D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307-336 (2005).
26. Lopez-Souza, N. et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123, 1384-1390 e1382 (2009).
27. Sykes, A. etal. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J. Allergy Clin. Immunol. 129, 1506-1514 e1506 (2012).
28. Gehlhar, K., Bilitewski, C., Reinitz-Rademacher, K., Rohde, G. & Bufe, A. Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy 36, 331-337 (2006).
29. Bufe, A., Gehlhar, K., Grage-Griebenow, E. & Ernst, M. Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int. Arch Allergy Immunol. 127, 82-88 (2002).
30. Gill, M.A. et al. Counterregulation between the FcepsilonRI pathway and antiviral responsesinhuman plasmacytoid dendritic cells. J. Immunol.184, 5999-6006 (2010).
31. Cakebread, J.A. et al. Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J. Allergy Clin. Immunol. 127, 1148-1154 e1149 (2011).
32. McNamara, P.S., Kicic, A., Sutanto, E.N., Stevens, P.T. & Stick, S.M. Comparison of techniques for obtaining lower airway epithelial cells from children. Eur. Respir. J. 32, 763-768 (2008).
33. Fonceca, A.M., Flanagan, B.F., Trinick, R., Smyth, R.L & McNamara, P.S. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection. Thorax 67, 42-48 (2012).
34. Lopez-Guisa, J.M. et al. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J. Allergy Clin. Immunol. 129, 990-997.e6 (2012).
35. Vareille, M. et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax 67, 517-525 (2012).
36. Pizzichini, M.M. et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am. J. Respir. Crit. Care. Med 158, 1178-1184 (1998).
37. Hewson, CA. et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-kappaB and EGFR pathways. Eur. Respir. J. 36, 1425-1435 (2010).
38. Laza-Stanca, V. et al. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog. 7, e1002114 (2011).
39. Koltsida, O. et al. IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol. Med. 3, 348-361 (2011).
40. Wang, Q. et al. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyper-responsiveness. PLoS Pathog. 7, e10020702011).
41. Moffatt, M.F. et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363, 1211-1221 (2010).
42. Moffatt, M.F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470-473 (2007).
43. Gupta, A. et al. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am. J. Respir. Crit. Care Med. 184, 1342-1349 (2011).
44. Bush, A. & Saglani, S. Management of severe asthma in children. Lancet 376, 814-825 (2010).
45. Bracken, M.etal. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis. Child 94, 780-784 (2009).
46. Gielen, V, Johnston, S.L. & Edwards, M.R. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur. Respir. J. 36, 646-654 (2010).
47. Johnston, S.L. & Tyrrell, D.A. Diagnstic Procedures forViral, Rickettsial and Chylamydial Infections. American Public Health Association, Washington, D.C., 2005).